AXL and thyroid cancer: Recently, Krishnamoorthy et al. reported that 17-AAG induces the down-regulation of endogenous or ectopically expressed AXL protein in thyroid cancer cell lines and in HeLa cells in a time- and dose-dependent manner, leading to the inhibition of AXL-mediated signaling and biological activity [35].